Joel Moss Selected Research

Tuberous Sclerosis (Bourneville's Disease)

1/2022	ETV2 regulates PARP-1 binding protein to induce ER stress-mediated death in tuberin-deficient cells.
11/2021	Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice.
10/2021	Histopathological features of fibrous cephalic plaques in tuberous sclerosis complex.
1/2021	Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like Cells.
12/2019	Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells.
11/2019	Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.
1/2019	A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis.
1/2019	Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.
1/2018	Fibrous cephalic plaques in tuberous sclerosis complex.
1/2018	Effect of beta-agonists on LAM progression and treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel Moss Research Topics

Disease

101	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2022 - 03/2002
50	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 03/2002
47	Neoplasms (Cancer) 01/2022 - 09/2005
29	Lung Diseases (Lung Disease) 01/2022 - 12/2004
21	Angiomyolipoma 01/2019 - 12/2004
18	Lymphangiomyoma 01/2018 - 02/2005
16	Cysts 01/2022 - 07/2006
11	Idiopathic Pulmonary Fibrosis 01/2021 - 12/2005
11	Pneumothorax 11/2017 - 12/2005
10	Inflammation (Inflammations) 01/2021 - 09/2003
10	Disease Progression 01/2019 - 02/2008
9	Dyspnea (Shortness of Breath) 01/2021 - 12/2005
9	Carcinogenesis 02/2020 - 09/2005
7	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 03/2002
7	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2007
6	Angiofibroma 01/2022 - 09/2005
6	Pleural Effusion (Pleural Effusions) 01/2018 - 04/2006
6	Hamartoma 01/2018 - 12/2005
5	Fibrosis (Cirrhosis) 01/2022 - 09/2005
5	Diarrhea 12/2020 - 03/2002
5	Asthma (Bronchial Asthma) 01/2018 - 06/2006
5	Infections 12/2016 - 04/2002
5	Chylothorax 01/2016 - 12/2005
5	Fibroma (Fibromatosis) 11/2015 - 09/2005
5	Hemorrhage 03/2011 - 12/2005
5	Cystic Fibrosis (Mucoviscidosis) 06/2007 - 01/2002
4	Melanoma (Melanoma, Malignant) 01/2020 - 02/2009
4	Rare Diseases (Rare Disease) 01/2018 - 12/2005
4	Leiomyoma (Uterine Fibroids) 09/2013 - 03/2010
4	Lymphadenopathy 08/2013 - 05/2009
4	Hypoxia (Hypoxemia) 06/2013 - 12/2003
4	Adenocarcinoma 08/2006 - 05/2003
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2022 - 12/2005
3	Sarcoidosis (Schaumann Disease) 01/2021 - 09/2009
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 05/2011
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 09/2012
3	Adenocarcinoma of Lung 01/2018 - 01/2003
3	Lymphatic Abnormalities 09/2012 - 12/2004
2	Breast Neoplasms (Breast Cancer) 11/2021 - 02/2009
2	Rheumatoid Arthritis 01/2021 - 11/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 01/2013
2	Leukopenia 01/2018 - 01/2015
2	Ascites 08/2016 - 01/2007
2	Chylous Ascites 08/2016 - 11/2007
2	Cholera 08/2007 - 03/2002
1	Virus Diseases (Viral Diseases) 12/2022

Drug/Important Bio-Agent (IBA)

84	lipoarabinomannan (LAM)IBA 01/2022 - 03/2002
39	trans-sodium crocetinate (crocetin)IBA 01/2022 - 12/2004
26	Sirolimus (Rapamycin)FDA Link 01/2021 - 09/2005
18	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2002
8	TOR Serine-Threonine KinasesIBA 11/2021 - 07/2006
7	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2011
7	Vascular Endothelial Growth Factor DIBA 01/2021 - 05/2009
7	Messenger RNA (mRNA)IBA 01/2018 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
6	Cytotoxins (Cytolysins)IBA 12/2020 - 01/2002
6	Adenosine Diphosphate (ADP)IBA 01/2019 - 04/2002
5	Estrogens (Estrogen)FDA Link 01/2014 - 12/2004
4	Oxygen (Dioxygen)IBA 01/2022 - 12/2003
4	CollagenIBA 01/2022 - 09/2007
4	Carbon MonoxideIBA 01/2021 - 01/2018
4	EnzymesIBA 12/2020 - 01/2006
3	CytokinesIBA 01/2021 - 09/2003
3	Virulence Factors (Pathogenicity Factors)IBA 12/2020 - 03/2002
3	Cholera ToxinIBA 12/2020 - 03/2002
3	Bacterial ToxinsIBA 02/2020 - 01/2005
3	Arginine (L-Arginine)FDA Link 02/2020 - 12/2014
3	Bronchodilator Agents (Bronchodilators)IBA 01/2019 - 12/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 08/2010
3	Melanoma-Specific AntigensIBA 03/2015 - 01/2008
3	human neutrophil peptide 1IBA 12/2014 - 06/2006
3	Tuberous Sclerosis Complex 2 ProteinIBA 01/2011 - 09/2005
3	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2008 - 03/2006
3	Progesterone FDA LinkGeneric 01/2005 - 07/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 09/2013
2	SteroidsIBA 01/2020 - 02/2012
2	HydrolasesIBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2018
2	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2018 - 08/2011
2	Galectin 3 (LGALS3)IBA 11/2017 - 03/2014
2	Small Interfering RNA (siRNA)IBA 12/2016 - 01/2013
2	LigandsIBA 10/2016 - 08/2007
2	Poly Adenosine Diphosphate RiboseIBA 02/2016 - 11/2013
2	MTOR InhibitorsIBA 01/2016 - 01/2015
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 09/2015 - 09/2007
2	Bcl-2-Like Protein 11IBA 09/2015 - 01/2013
2	AntibodiesIBA 05/2015 - 08/2013
2	Interleukin-6 (Interleukin 6)IBA 05/2015 - 03/2011
2	Hormones (Hormone)IBA 09/2013 - 02/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2011 - 07/2002
2	ChemokinesIBA 01/2010 - 02/2009
2	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2010 - 09/2005
2	Tuberous Sclerosis Complex 1 ProteinIBA 11/2007 - 09/2005
1	Nucleic AcidsIBA 12/2022
1	ChromatinIBA 12/2022
1	Collagenases (Collagenase)FDA Link 01/2022

Therapy/Procedure

21	Therapeutics 01/2020 - 03/2002
7	Lung Transplantation 11/2017 - 12/2003
4	Pleurodesis 11/2017 - 04/2002
2	Nephrectomy 06/2011 - 01/2007